The PRIDE Syndrome: Dermatological Side Effects of EGFR Inhibitors

    August 2006 in “ British Journal of Dermatology
    Mario E. Lacouture, Susan Lai
    TLDR PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.
    The PRIDE syndrome, associated with the use of Epidermal Growth Factor Receptor (EGFR) inhibitors, encompassed a range of dermatological side effects including papulopustules, paronychia, regulatory abnormalities of hair growth, itching, and dryness. The study highlighted the need for awareness and management of these adverse effects in patients undergoing cancer treatment with EGFR inhibitors. The authors, M.E. Lacouture and S.E. Lai, from the Cancer Skin Care Program and SERIES Clinic at Northwestern University, emphasized the importance of dermatological care in improving the quality of life for these patients.
    Discuss this study in the Community →

    Cited in this study

    1 / 1 results